The steady growth trajectory of Europe’s autoimmune disease diagnostics market can be attributed to several factors. Primarily, the rising incidence of autoimmune disorders across the region ...

The surge in autoimmune diseases, propelled by factors such as genetic predisposition, environmental triggers, and lifestyle changes, underpins the robust growth of the diagnostics market. With ...

A public health advocacy group is urging the B.C. government to end its contract with the American company that owns LifeLabs ...

The market expects Quest Diagnostics (DGX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

Quest Diagnostics DGX is set to release its first-quarter 2025 results on April 22, before the market opens. The renowned ...

GRAIL's groundbreaking Galleri test, detecting 50+ cancers, FDA status, and strategic growth make it a top investment with ...

Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...

The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.

Genomic Testing Cooperative (GTC) is expanding into the European market by partnering with German laboratory Labor Dr.

The sample is then sent to a Quest Diagnostics laboratory for testing, with results shared electronically with both the physician and patient. While the service is not intended to replace pelvic ...